Skip to content

Mirum Pharmaceuticals, Inc. MIRM Other Non-Current Assets

Other Non-Current Assets at other companies

Arrowhead Research logo
Arrowhead ResearchARWR
$4.89M+272%
Alkermes logo
AlkermesALKS
$59.36M+223%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$135.56M+2.8%
TG Therapeutics logo
TG TherapeuticsTGTX
$2.02M-1.3%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
LQD
Liquidia CorporationLQDA

Other financials

Income statement

See full
Revenue$159.9M+43.3%
Operating income-$789.5M-5,100%
Net income-$790.2M-5,284%
EPS (diluted)-$13.43-4,377%

Balance sheet

See full
Cash & equivalents$261.5M+43.5%
Total debt$13.5M+56.4%
Total equity$242.5M+4.0%
Total assets$890.9M+29.1%

Cash flow

See full
Operating cash flow-$228.8M-11,566%
CapEx$664.0K+1,520%
Free cash flow-$229.4M-11,360%

Valuation

See full
Market cap$6.53B+152%
Enterprise value$6.28B+162%
P/S11.5×+4.6×

Profitability

See full
Operating margin-139.8%-168pp
Net margin-140.2%-169pp
FCF margin-30.3%

Returns & leverage

See full
Return on equity-335.8%-377pp
Debt / equity0.1×0.0×
Current ratio2.1×-1.1×

Where this comes from

Reported directly by Mirum Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesNoncurrent.

The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mirum Pharmaceuticals, Inc.'s other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mirum Pharmaceuticals, Inc.'s other non-current assets?
Mirum Pharmaceuticals, Inc. (MIRM) reported other non-current assets of $252K in Q1 2026.
How has Mirum Pharmaceuticals, Inc.'s other non-current assets changed year-over-year?
Mirum Pharmaceuticals, Inc.'s other non-current assets decreased by 95.4% year-over-year, from $5.47M to $252K.
What is the long-term trend for Mirum Pharmaceuticals, Inc.'s other non-current assets?
Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s other non-current assets has grown at a -100.0% compound annual growth rate (CAGR), from $1.27M to $0.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.